Cisplatin in Combination with Apigenin Inhibits Human Osteosarcoma Cells Proliferation by Promoting Osteogenic Differentiation: A Mechanistic Insight

ABSTRACT

Background: Osteosarcoma, the predominant primary bone cancer in the pediatric and adolescent population globally, exhibits a relatively low annual incidence but contributes significantly to morbidity and mortality. Objectives: The current study aims to explore the impact of cisplatin, apigenin, and their combination on human osteosarcoma cell line (MG-63) osteosarcoma cells, given the challenges in clinical treatment such as chemotherapy’s adverse effects, resistance development, and relapses. Materials and Methods: Cytotoxicity assessment using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was conducted for cisplatin, apigenin, and their combination. Apoptotic potential was evaluated through ethidium bromide (EtBr)/acridine orange (AO) dual staining for the combination treatment. Reactive oxygen species (ROS) production and cell cycle arrest were analyzed posttreatment with the cisplatin + apigenin combination using 2′-7′-dichlorodihydrofluorescein diacetate (DCF-DA) staining and fluorescence-activated cell sorting (FACS) analysis, respectively. Proapoptotic and antiapoptotic gene expression was assessed via quantitative polymerase chain reaction (qPCR) analysis. Additionally, messenger ribonucleic acid (mRNA) and protein expression of B-cell-specific Moloney murine leukemia virus integration site 1 (BMIL1) were analyzed in both untreated and cisplatin + apigenin treated cells. Enzymelinked immunosorbent assay (ELISA) analysis was performed for p16INK4a, E-cadherin, and Notch1. Results: Results indicated that the combination treatment significantly inhibited MG-63 cell proliferation compared to individual treatments. Enhanced apoptosis and ROS production were observed in the combination treatment, along with cell cycle arrest at the subG0-G1 phase. Furthermore, the combination downregulated BMIL1 and Bcl-2 expression while upregulating mRNA expression of Bax, Caspase-3, Caspase-9, Apaf-1, and p53. Gene expression results corroborated BMIL1 downregulation in the combination treatment. Additionally, protein levels of p16INK4a and E-cadherin were significantly decreased in the combination treatment compared to individual treatments and untreated control. Conclusions: In conclusion, cisplatin and apigenin combination exhibited superior efficacy against osteosarcoma.

KEYWORDS

• MG-63
• osteosarcoma
• apigenin
• cisplatin
• combination
• apoptosis

Showing references and in-text citations exactly as published.

• DOI10.1177/09731296241299496Copy

RELATED ARTICLES

Matched on section and article type within this issue of PM.

• Article · VOLUME 21, ISSUE 3Evaluation and Analysis of Traditional Chinese Medicine Treatment of Bovine Viral Diarrhea/Mucosal Disease Based on Network Pharmacology and in vitro StudiesLiang Chen, Shijie Lan, Sisi Shen, Jiahui Wang, Xuesong Liu, Botao Jiang, Peng Zhong, Bochao Liu, Shuang Yao, Pingwei Qin, Wanyu Feng · pp. 765–780Original Research ArticleSame type: Article
• Article · VOLUME 21, ISSUE 3Cinnamon Polyphenols Ameliorate the Dysregulation of Cardiac Energy and Autophagic Homeostasis in Rats with Diabetic Cardiomyopathy via the mTOR/PGC1α PathwayXu Zhang, Xiao-Ting Zhang, Shi-Yu Wu, Ming-Qiao Hu, Xu Xu, Jian-Ping Gao · pp. 781–792Original Research ArticleSame type: Article
• Article · VOLUME 21, ISSUE 3Farnesol Inhibits Cell Viability and Activates Apoptosis in Glioma C6 Cells via Downregulating Phosphoinositide 3-kinase (PI3K)/Protein Kinase B (AKT)/Mammalian Target of Rapamycin (mTOR) PathwayChao Gao, Shunzhan Su, Qi Guan, Xiaoxia Huang, Haichuan Tan, Zhuang Qiu, Lili Su, Shengcao Cao · pp. 793–804Original Research ArticleSame type: Article
• Article · VOLUME 21, ISSUE 3Galangin Ameliorates Gamma Radiationinduced DNA Damage and Subsequent Chromosomal Aberrations in Human Blood LymphocytesHuiying Zhao, Yongshou Xia · pp. 805–817Original Research ArticleSame type: Article